A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors
Jacobio Pharmaceuticals Co., Ltd.
Jacobio Pharmaceuticals Co., Ltd.
Novartis
Allist Pharmaceuticals, Inc.
Exelixis
Novartis
AstraZeneca
OHSU Knight Cancer Institute
University of Michigan Rogel Cancer Center